CR Bard stent cleared by FDA:
This article was originally published in Clinica
CR Bard has received US FDA 510(k) clearance to market its Memotherm FLEXX, a biliary stent for treating malignant biliary obstructions. The device can negotiate sinuous anatomy and permit the stent to conform with curves in the biliary system, the company said. The Memotherm FLEXX also provides the radial strength to maintain patency.